![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 11, 2013 12:44:50 PM
On a brighter note: Biotech stocks are news driven; fundamentally, we have all of the same potential (just with a higher share base). Management have every intention to move us above $.10; or they wont get their extra $8mm in financing. Moreover, we are in uncharted territory with MANF...if things all work out.......getting to $.20 (and way beyond) is very attainable to say the least.
Lastly, I would not knock Gerald on the timing of the LymPro news release; just ridiculous timing to update the market this week (but as the markets are stabilizing; next week should be a more healthy backdrop.).
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM